Delfi Diagnostics is developing proprietary liquid biopsy-based diagnostic technology for the early detection of cancer.
Alto Neuroscience is a biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.
Nuvaira is developing a novel bronchoscopic device and procedure to treat lung diseases, including chronic obstructive pulmonary disease (COPD).
The strength of our portfolio is rooted in the world class visionaries who lead these companies. Together we are creating the next generation of HealthTech.